LEADER 03094nam  22005775  450 
001 9910300224903321
005 20200703234725.0
010   $a3-319-12715-2
024 7 $a10.1007/978-3-319-12715-6
035   $a(CKB)3710000000359087
035   $a(EBL)1998674
035   $a(SSID)ssj0001452243
035   $a(PQKBManifestationID)11934967
035   $a(PQKBTitleCode)TC0001452243
035   $a(PQKBWorkID)11487701
035   $a(PQKB)11276762
035   $a(DE-He213)978-3-319-12715-6
035   $a(MiAaPQ)EBC1998674
035   $a(PPN)18449396X
035   $a(EXLCZ)993710000000359087
100   $a20150217d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aNeuroimaging Pharmacopoeia /$fedited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (376 p.)
300   $aDescription based upon print version of record.
311   $a3-319-12714-4 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aAnti-Tumor and Immunosuppressive Agents -- Contrast Agents -- Illicit, Recreational, Abuse -- Anti-Seizure -- Hemostatic, Embolization -- Anticoagulant -- Radiopharmaceuticals -- Antibiotics -- Antipsychotic, Neurodegenerative -- Electrolytes, Minerals, and Fluid Regulating Agents -- Cosmetic Fillers -- Miscellaneous -- Drug Delivery Mechanisms.
330   $aThis book reviews the imaging features associated with selected classes of pharmaceuticals and drugs on brain, head and neck, and spine and explains the implications of the imaging findings for the neuroradiologist and the clinician. Some agents produce characteristic abnormalities with distinctive imaging features, while others have a spectrum of manifestations on imaging. Still further agents produce rather nonspecific changes on imaging, requiring a differential diagnosis. In this book, informative cases are depicted by rich images, with concise accompanying explanatory text that reviews the class of agent and the mechanism of action and discusses image interpretation and its significance.
606   $aNeuroradiology
606   $aPharmacology
606   $aNeuroradiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H2903X
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
615  0$aNeuroradiology.
615  0$aPharmacology.
615 14$aNeuroradiology.
615 24$aPharmacology/Toxicology.
676   $a616.0757
702   $aGinat$b Daniel Thomas$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aSmall$b Juan E$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aSchaefer$b Pamela Whitney$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300224903321
996   $aNeuroimaging Pharmacopoeia$92994417
997   $aUNINA